NCT01131767View on ClinicalTrials.gov

Bioequivalence Study of Naproxen Sodium 220 mg & Pseudoephedrine HCl 120 mg ER Tablets of Dr. Reddy's Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

Naproxen Sodium & Pseudoephedrine HCl

Naproxen Sodium 220 mg and Pseudoephedrine Hydrochloride 120 mg Extended Release Tablets

Trial Locations (1)

560034

Lotus Labs Private Limited, Bangalore

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY